Features
Nikon Lenswear’s New National Consumer Campaign Demonstrates How a Detail Can Inspire
Monday, October 17 2022 | 14 h 47 min | NewsPress Release
Nikon Optical Canada launches a new national
Gene Therapy Luxturna® Now Reimbursed in Quebec for People with Previously Untreatable Inherited Vision Loss
Monday, October 17 2022 | 14 h 25 min | News, Press Release,
Novartis Pharmaceuticals Canada announces Luxturna® (voretigene neparvovec) is now available to Quebec patients with vision loss due to inherited retinal dystrophy caused by confirmed biallelic RPE65 mutations under the province's public health plan.
EssilorLuxottica Earns 6th Spot on 2022 Fortune Change the World List
Monday, October 17 2022 | 10 h 08 min | News, Press Release,
EssilorLuxottica has been named on the 2022 Fortune Change the World list, taking the 6th spot within this annual prestigious ranking.
Information Technology and Innovation: One of FYidoctors’ Driving Factors for the Future
Monday, October 17 2022 | 08 h 29 min | News, Press Release,
For over two decades, or most of his career, Kevin Bingham has been dedicating his time to improving and prioritizing the function of Information Technology (IT) and Innovation in the workplace.
2022 World Sight Day – Photo Competition
Thursday, October 13 2022 | 11 h 04 min | News, Press Release,
The IAPB World Sight Day 2022 Photo Competition is an opportunity for amateur and professional photographers to demonstrate their skills and share with the world what they see and what it means to #LoveYourEyes.
Nikon Lenswear’s New National Consumer Campaign Demonstrates How a Detail Can Inspire
Monday, October 17 2022 | 14 h 47 min | NewsPress Release
Nikon Optical Canada launches a new national
Gene Therapy Luxturna® Now Reimbursed in Quebec for People with Previously Untreatable Inherited Vision Loss
Monday, October 17 2022 | 14 h 25 min | News, Press Release,
Novartis Pharmaceuticals Canada announces Luxturna® (voretigene neparvovec) is now available to Quebec patients with vision loss due to inherited retinal dystrophy caused by confirmed biallelic RPE65 mutations under the province's public health plan.
EssilorLuxottica Earns 6th Spot on 2022 Fortune Change the World List
Monday, October 17 2022 | 10 h 08 min | News, Press Release,
EssilorLuxottica has been named on the 2022 Fortune Change the World list, taking the 6th spot within this annual prestigious ranking.
Information Technology and Innovation: One of FYidoctors’ Driving Factors for the Future
Monday, October 17 2022 | 08 h 29 min | News, Press Release,
For over two decades, or most of his career, Kevin Bingham has been dedicating his time to improving and prioritizing the function of Information Technology (IT) and Innovation in the workplace.
2022 World Sight Day – Photo Competition
Thursday, October 13 2022 | 11 h 04 min | News, Press Release,
The IAPB World Sight Day 2022 Photo Competition is an opportunity for amateur and professional photographers to demonstrate their skills and share with the world what they see and what it means to #LoveYourEyes.
Nikon Lenswear’s New National Consumer Campaign Demonstrates How a Detail Can Inspire
Monday, October 17 2022 | 14 h 47 min | NewsPress Release
Nikon Optical Canada launches a new national
Gene Therapy Luxturna® Now Reimbursed in Quebec for People with Previously Untreatable Inherited Vision Loss
Monday, October 17 2022 | 14 h 25 min | News, Press Release,
Novartis Pharmaceuticals Canada announces Luxturna® (voretigene neparvovec) is now available to Quebec patients with vision loss due to inherited retinal dystrophy caused by confirmed biallelic RPE65 mutations under the province's public health plan.
EssilorLuxottica Earns 6th Spot on 2022 Fortune Change the World List
Monday, October 17 2022 | 10 h 08 min | News, Press Release,
EssilorLuxottica has been named on the 2022 Fortune Change the World list, taking the 6th spot within this annual prestigious ranking.
Information Technology and Innovation: One of FYidoctors’ Driving Factors for the Future
Monday, October 17 2022 | 08 h 29 min | News, Press Release,
For over two decades, or most of his career, Kevin Bingham has been dedicating his time to improving and prioritizing the function of Information Technology (IT) and Innovation in the workplace.
2022 World Sight Day – Photo Competition
Thursday, October 13 2022 | 11 h 04 min | News, Press Release,
The IAPB World Sight Day 2022 Photo Competition is an opportunity for amateur and professional photographers to demonstrate their skills and share with the world what they see and what it means to #LoveYourEyes.
Nikon Lenswear’s New National Consumer Campaign Demonstrates How a Detail Can Inspire
Monday, October 17 2022 | 14 h 47 min | NewsPress Release
Nikon Optical Canada launches a new national
Gene Therapy Luxturna® Now Reimbursed in Quebec for People with Previously Untreatable Inherited Vision Loss
Monday, October 17 2022 | 14 h 25 min | News, Press Release,
Novartis Pharmaceuticals Canada announces Luxturna® (voretigene neparvovec) is now available to Quebec patients with vision loss due to inherited retinal dystrophy caused by confirmed biallelic RPE65 mutations under the province's public health plan.
EssilorLuxottica Earns 6th Spot on 2022 Fortune Change the World List
Monday, October 17 2022 | 10 h 08 min | News, Press Release,
EssilorLuxottica has been named on the 2022 Fortune Change the World list, taking the 6th spot within this annual prestigious ranking.
Information Technology and Innovation: One of FYidoctors’ Driving Factors for the Future
Monday, October 17 2022 | 08 h 29 min | News, Press Release,
For over two decades, or most of his career, Kevin Bingham has been dedicating his time to improving and prioritizing the function of Information Technology (IT) and Innovation in the workplace.
2022 World Sight Day – Photo Competition
Thursday, October 13 2022 | 11 h 04 min | News, Press Release,
The IAPB World Sight Day 2022 Photo Competition is an opportunity for amateur and professional photographers to demonstrate their skills and share with the world what they see and what it means to #LoveYourEyes.
